Ferlay J, Shin H R, Bray F, Forman D, Mathers C, Parkin D M. Int. J. Cancer, 2011, 127: 2893—917
[2]
Shapiro J A, Seeff L C, Thompson T D, Nadel M R, Klabunde C N, Vernon S W. Colorectal Cancer Test Use from the 2005 National Health Interview Survey. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2008, 17: 1623—1630
[3]
Chan A T, Giovannucci E L. Gastroenterology, 2010, 138: 2029—2043 e10
[4]
Routine Aspirin or Nonsteroidal Anti-Inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U. S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 2007, 146: 361—364
[5]
Rothwell P M, Wilson M, Elwin C E, Norrving B, Algra A, Warlow C P, Meade T W. The Lancet, 2010, 376: 1741—1750
[6]
Rothwell P M, Fowkes F G, Belch J F, Ogawa H, Warlow C P, Meade T W. The Lancet, 2011, 377: 31—41
[7]
Cook N R, Lee I M, Gaziano J M, Gordon D, Ridker P M, Manson J E, Hennekens C H, Buring J E. JAMA, 2005, 294: 47—55
[8]
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N. Engl. J. Med., 1989, 321: 129—135
[9]
Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian Z R, Baba Y, Shima K, Sun R, Nosho K, Meyerhardt J A, Giovannucci E, Fuchs C S, Chan A T, Ogino S. N. Engl. J. Med., 2012, 367: 1596—1606
[10]
Aspirin for the Prevention of Cardiovascular Disease: U. S. Preventive Services Task Force Recommendation Statement. Ann. Intern. Med., 2009, 150: 396—404
[11]
Cole B F, Logan R F, Halabi S, Benamouzig R, Sandler R S, Grainge M J, Chaussade S, Baron J A. J. Natl. Cancer Inst., 2009, 101: 256—266
[12]
Sturmer T, Glynn R J, Lee I M, Manson J E, Buring J E, Hennekens C H. Ann. Intern. Med., 1998, 128: 713—720
[13]
Burn J, Bishop D T, Mecklin J P, Macrae F, Moslein G, Olschwang S, Bisgaard M L, Ramesar R, Eccles D, Maher E R, Bertario L, Jarvinen H J, Lindblom A, Evans D G, Lubinski J, Morrison P J, Ho J W, Vasen H F, Side L, Thomas H J, Scott R J, Dunlop M, Barker G, Elliott F, Jass J R, Fodde R, Lynch H T, Mathers J C. N. Engl. J. Med., 2008, 359: 2567—2578
[14]
Burn J, Gerdes A, Macrae F, Mecklin J, Moslein G, Olschwang S, Eccles D, Evans G, Bertario L, Bisgaard M, Dunlop M, Ho J W, Hodgson S, Lindblom A, Lubinski J, Morrison P J, Murday V, Ramesar R, Side L, Scott R J, Thomas J W, Vasen H F, Barker G, Crawford G, Elliott F, Movahedi M, Pylvanainen K, Wijnen J, Fodde R, Lynch H, Mathers J C, Bishop D T. The Lancet, 2011, 378: 2081—2087
[15]
Sostres C, Lanas A. Nature Reviews Gastroenterology & Hepatology, 2011, 8: 385—394
[16]
Patrono C, Baigent C, Hirsh J, Roth G. Antiplatelet Drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 2008, 133:199S—233S
[17]
Ridker P M, Cook N R, Lee I M, Gordon D, Gaziano J M, Manson J E, Hennekens C H, Buring J E. N. Engl. J. Med., 2005, 352: 1293—1304
[18]
Chan A T, Ogino S, Fuchs C S. JAMA, 2009, 302: 649—658
